World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
39944
World Ranking
13424
National Ranking
6827

Overview

Christopher R. Flowers is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their work primarily spans the field of Medicine, with a focus on several key subfields including Pathology and Forensic Medicine, Oncology, Genetics, Immunology, and Molecular Biology.

The researcher's scientific output covers a variety of main topics, notably:

  • Lymphoma Diagnosis and Treatment
  • CAR-T cell therapy research
  • Chronic Lymphocytic Leukemia Research
  • Viral-associated cancers and disorders
  • CNS Lymphoma Diagnosis and Treatment
  • Immune Cell Function and Interaction
  • Cancer Genomics and Diagnostics

Christopher R. Flowers has contributed frequently to several prominent publication venues. These include:

  • Blood
  • Journal of Clinical Oncology
  • Clinical Lymphoma Myeloma & Leukemia
  • Blood Advances
  • Leukemia & lymphoma/Leukemia and lymphoma

Some of the recent papers involving Christopher R. Flowers are:

  • "Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society" (2020), published in CA A Cancer Journal for Clinicians
  • "International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI" (2020), published in Blood
  • "Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial" (2024), published in Nature Medicine
  • "Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update" (2023), published in Journal of Clinical Oncology
  • "Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma" (2020), published in Blood Advances

Their work often involves collaboration with several frequent co-authors:

  • Loretta J. Nastoupil
  • Jason R. Westin
  • Sairah Ahmed
  • Sattva S. Neelapu
  • Ranjit Nair

Best Publications

  • Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society

    Kevin C. Oeffinger;Elizabeth T. H. Fontham;Ruth Etzioni;Abbe Herzig

  • Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society

    Andrew M.D. Wolf;Elizabeth T.H. Fontham;Timothy R. Church;Christopher R. Flowers

  • American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer

    Gary H. Lyman;Alok A. Khorana;Anna Falanga;Daniel Clarke-Pearson

  • Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

    Nigel S Key;Alok A Khorana;Nicole M Kuderer;Kari Bohlke

  • Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014

    Gary H. Lyman;Gary H. Lyman;Kari Bohlke;Alok A. Khorana;Nicole M. Kuderer

  • PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma

    Ajay K. Gopal;Ajay K. Gopal;Brad S. Kahl;Sven de Vos;Nina D. Wagner-Johnston

  • 2016 US lymphoid malignancy statistics by World Health Organization subtypes.

    Lauren R. Teras;Carol E. DeSantis;James R. Cerhan;Lindsay M. Morton

  • Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.

    Anupama Reddy;Jenny Zhang;Nicholas S. Davis;Andrea B. Moffitt

  • American Cancer Society lung cancer screening guidelines

    Richard Wender;Elizabeth T.H. Fontham;Ermilo Barrera;Ermilo Barrera;Graham A. Colditz

  • Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study

    Carla Casulo;Michelle Byrtek;Keith L. Dawson;Xiaolei Zhou

  • Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society

    Elizabeth T.H. Fontham;Andrew M.D. Wolf;Timothy R. Church;Ruth Etzioni;Ruth Etzioni

  • Genetic heterogeneity of diffuse large B-cell lymphoma

    Jenny Zhang;Vladimir Grubor;Cassandra L. Love;Anjishnu Banerjee

  • The genetic landscape of mutations in Burkitt lymphoma

    Cassandra Love;Zhen Sun;Dereje Jima;Guojie Li

  • Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Laurie H. Sehn;Alex F. Herrera;Christopher R. Flowers;Manali K. Kamdar

  • Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline

    Christopher R. Flowers;Jerome Seidenfeld;Eric J. Bow;Clare Karten

  • Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update

    Randy A Taplitz;Erin B Kennedy;Eric J Bow;Jennie Crews

  • Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.

    Adam M Petrich;Mitul Gandhi;Borko Jovanovic;Jorge J Castillo

  • Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities.

    Mohamed L. Sorror;Michael B. Maris;Barry Storer;Brenda M. Sandmaier

  • Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors.

    Razvan Diaconescu;Christopher R. Flowers;Barry Storer;Mohamed L. Sorror

  • Follicular Lymphoma in the United States: First Report of the National LymphoCare Study

    Jonathan W. Friedberg;Michael D. Taylor;James R. Cerhan;Christopher R. Flowers

Frequent Co-Authors

Sagar Lonial
Sagar Lonial Emory University
Jonathan W. Friedberg
Jonathan W. Friedberg University of Rochester
James R. Cerhan
James R. Cerhan Mayo Clinic
Gilles Salles
Gilles Salles Memorial Sloan Kettering Cancer Center
Luis Fayad
Luis Fayad The University of Texas MD Anderson Cancer Center
Ian W. Flinn
Ian W. Flinn Sarah Cannon Research Institute
Andrew D. Zelenetz
Andrew D. Zelenetz Memorial Sloan Kettering Cancer Center
John P. Leonard
John P. Leonard Cornell University
Michael Wang
Michael Wang Argonne National Laboratory

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in Medicine but prefer alternative routes or the flexibility of online learning, there are several related degrees and career pathways to explore. For nurses aiming to advance their careers affordably, cheap online dnp programs provide a pathway to leadership roles and higher salaries without the need for a traditional, on-campus experience.

Aspiring pharmacists can consider a 3 year online pharmd, which offers an accelerated and flexible approach to earning a pharmacy doctorate. For those interested in healthcare administration and managing patient data, an online mhi (Master's in Health Information) enables you to develop vital skills in a growing field, often at a lower cost than in-person programs.

If you want to enter the healthcare industry quickly and with minimal investment, the average cost of medical billing and coding program indicates entry-level opportunities that can be pursued affordably and almost entirely online. Each of these online degree options provides unique benefits and can lead to rewarding careers in healthcare, offering flexibility for busy students or working professionals.

Best Scientists Citing Christopher R. Flowers

Trending Scientists